The ski/sno protooncogenes encode nuclear proteins that may act as transcription factors. We examined ski and sno mRNA expression in hemolymphopoietic lineages. The ski protooncogene is expressed in B-and T-lineage cells, mature macrophages, and mast cells. In normal murine marrowderived progenitors analyzed by single-cell reverse transcription-polymerase chain reaction (RT-PCR), skiexpression is limited to dual-lineage megakaryocyte/erythrocyte colony-starts. Expression of sno is more limited than ski in mature cells; it is expressed in T lymphopoietic cells, but not in B-lineage cells. The sno protooncogene is expressed more widely than ski in myeloid progenitors, as it is found consis-EVERAL MEMBERS of the ski/sno protooncogene family have been isolated and characterized, but the function(s) of these genes remains to be understood. Both the vski and the related sno (for ski-related novel) gene4 have been shown to convert nonmuscle cells to the myogenic lineage.'" Transgenic mice overexpressing a truncated cloned chicken c-ski cDNA in their skeletal muscles exhibit a marked enlargement of these muscles and diminished body fat.' The ski and sno proteins are found in the nucleus, but are not in any major transcription factor or other protein fa mil^.^,^ Only to each other, are ski and sno closely related; sno was first isolated by crosshybridization with ski. lo The sno protooncogene transactivates a cotransfected myosin light chain enhancer in skeletal muscle cells (S. Pearson-White, manuscript submitted), consistent with a potential transcription factor function for the Sno protein. Expression of ski and sno genes has been found in every human tissue including hematopoietic cells (S. Pearson-White" and unpublished data, 1993), prompting us to examine the expression patterns more closely in hematopoietic cells. The v-ski oncogene has been found to cooperate with the protein tyrosine kinase oncogene v-sea in blocking erythroid differentiation and in inducing malignant erythroidmyeloid leukemias in Expression of ski mRNA has been examined in several myeloid cell lines, with the finding that ski levels are increased in response to serum or phorbol ester stimulation only in cell lines that differentiate along the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact. megakaryocytic pathway.I3 Here, we report that ski mRNA accumulation levels are cell cycle-regulated and respond to growth factor levels in myeloid cell cultures, and that ski and sno are differentially expressed in individual hematopoietic precursor cells. Our results contribute to evidence that these nuclear protooncogenes may play a role in hematopoietic development and point to distinct lineages in which each gene may play a role.
EVERAL MEMBERS of the ski/sno protooncogene family have been isolated and characterized, but the function(s) of these genes remains to be understood. Both the vski and the related sno (for ski-related novel) gene4 have been shown to convert nonmuscle cells to the myogenic lineage.'" Transgenic mice overexpressing a truncated cloned chicken c-ski cDNA in their skeletal muscles exhibit a marked enlargement of these muscles and diminished body fat.' The ski and sno proteins are found in the nucleus, but are not in any major transcription factor or other protein fa mil^.^,^ Only to each other, are ski and sno closely related; sno was first isolated by crosshybridization with ski. lo The sno protooncogene transactivates a cotransfected myosin light chain enhancer in skeletal muscle cells (S. Pearson-White, manuscript submitted), consistent with a potential transcription factor function for the Sno protein. Expression of ski and sno genes has been found in every human tissue including hematopoietic cells (S. Pearson-White" and unpublished data, 1993), prompting us to examine the expression patterns more closely in hematopoietic cells. The v-ski oncogene has been found to cooperate with the protein tyrosine kinase oncogene v-sea in blocking erythroid differentiation and in inducing malignant erythroidmyeloid leukemias in Expression of ski mRNA has been examined in several myeloid cell lines, with the finding that ski levels are increased in response to serum or phorbol ester stimulation only in cell lines that differentiate along the tently in tri-, dual-, and single-lineage progenitors. Both ski and sno are cell cycle-regulated in synchronized factor-dependent mouse myeloid cells. Expression of skimRNA peaks in mid G, in cells synchronized by isoleucine deprivation in the presence of growth factor, but falls off rapidly when growth factor is withdrawn. Expression of sno mRNA is maximal in early to mid G, and then oscillates as the cells continue through cycle. These results suggest that the ski/ sno protooncogenes play a role in hematopoiesis, growth factor responses, and cell cycle-regulation, with the two members of the family showing differing properties.
0 7995 by The American Society of Hematology. megakaryocytic pathway.I3 Here, we report that ski mRNA accumulation levels are cell cycle-regulated and respond to growth factor levels in myeloid cell cultures, and that ski and sno are differentially expressed in individual hematopoietic precursor cells. Our results contribute to evidence that these nuclear protooncogenes may play a role in hematopoietic development and point to distinct lineages in which each gene may play a role.
MATERIALS AND METHODS

Hematopoietic Colony Blots
Progenitor studies. Mouse hone marrow or fetal liver was disaggregated and plated at clonal density in methylcellulose. Single colonies of four to eight cells were picked and subdivided, with one cell used to isolate RNA, which was amplified using poly(A) PCR, a method designed for unbiased amplification of all cDNAs from a small ample.'^ The additional cells from each colony were cultured further, and the resulting hematopoietic differentiated phenotypes were identified by their morphology. For example, megakaryocytic cells were identified in methylcellulose cultures on the basis of their large size. The accuracy of such identifications was confirmed by morphologic assessment of cells spread on glass slides and stained either with May Gmnwald-Giemsa or specifically for acetylcholinesterase, a specific marker for murine megakaryocytes. Macrophage cDNA specifically hybridized with probes for lysozyme M and cfms.
In the poly(A) PCR method, reverse transcription of the RNA was primed with oligo(dT)24, and the resulting cDNA strands were tailed with poly(dA) and PCR-amplified using an oligo(dT)-containing primer. PCR-amplified samples (0.5 pg per lane) were electrophoresed on agarose gels, blotted to Hyhond N' (Amersham. Arlington Heights, IL), and probed as indicated. Equivalent amounts of cDNA were run in each lane as assessed by ethidium bromide fluorescence and hybridization to an oligo(dT) probe and probes for constitutively expressed genes, including L32 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; data not shown). AI1 cDNA probes (described below) included the extreme 3' untranslated region that is required for hybridization with cDNA amplified by the poly@) PCR method.
Studies in mature hematopoietic cell populations. Mature hematopoietic cell populations of 50 to 10,000 cells were taken from terminally differentiating mass cultures, RNA reverse-transcribed and amplified by poly(A) PCR. Mast cells were taken from CBNJ marrow cultures passaged for at least 4 weeks in interleukin(IL)-3. C57BL/6J spleen cell cultures stimulated with concanavalin A (ConA) were the source of T-cell samples. The cDNA samples from B cells specifically hybridized probes for lg(C-p) and rag-2, while Fetal liver studies. C57BU6J fetal (day 12.5 postcoitum) liver cells were separated by antibody panning and cultured. Bipotential macrophageE3-lymphocyte colonies no. 1 through 5 (Mac-l+/ B220+) were further cultured as de~cribed.'~ Briefly, panned Mac-l antibody-positive macrophages were cultured in macrophage colonystimulating factor (M-CSF; FLl-5). and B220-positive B cells were expanded in IL-7 (FL6-IO) for 12 days and processed as previously de~cribed.'~ Additional samples were processed directly after separation (FL12-16, 19-20) .
Probes. A 350-bp subclone from the 3' end of a mouse sno cDNA clone (S. Pearson-White, manuscript submitted) was used to probe poly(A) PCR blots. The entire mouse snoN cDNA was used to probe the other blots; both probes will hybridize with all spliced variants of sno mRNA. The 3' ski probe for the poly(A) PCR blot was made by reverse-transcribing 1 pg of total RNA from mouse 10T1/2 cells, using mixed hexamer primers and avian myeloblastosis virus (AMV) reverse transcriptase (Boehringer Mannheim, Indianapolis, IN), and then priming the PCR with primers from the 353 bp at the 3' end of a human ski cDNA (5' GACTGAGGCTGCAGC-A'ITGGAACA and CAGAITCAGTCGCTACTGAAGACAGA 3'4) using Vent DNA polymerase (New England Biolabs, Beverly, MA). The PCR conditions were 95°C for 2 minutes, then 95°C for 1 minute, 55°C for 1 minute, and 72°C for 1 minute for 34 cycles. The entire human (Fig 5) or mouse (Fig 6 ) ski cDNAs (S.P.-W. unpublished data, 1993) were used to probe the other blots. The mouse histone H2a probe was provided by William Marzluff.16 The mouse Id-l probe was provided by Harold Weintraub." The E12 probe was provided by Dr Charles P. Emerson Jr and was a 2.5-kb cDNA cloned from a C2C12 mouse myoblast cDNA library. It hybridizes to both E12 and E47 products of the E2A gene. The GAPDH probe was amplified from mouse liver RNA using commercially available primers (Clontech, Palo Alto, CA). Probe DNA fragments were purified by electrophoresis on agarose gels. The ethidium-stained band (of the appropriate size) was excised from the gel, run into 0.6% low-melt agarose ( M C , Rockland, ME), boiled, labeled by random priming (Boehringer Mannheim kit), and used as a probe.
RNA blots. Formaldehyde-1.2% agarose Northern blots were performed by standard methods'* using Zetabind (Cuno, Meriden, CT) nylon membrane and electroblotting for transfer. Blots were hybridized and washed at 65°C as de~cribed,'~ using 0.1 mg/mL Escherichia coli DNA (Sigma, St Louis, MO) as nonspecific carrier DNA. Blots were exposed to preflashed XAR-5 film (Eastman Kodak, Rochester, NY) with a single Cronex intensifying screen. Blot signals were quantified on a phosphorimager (Molecular Dynamics, Sunnyvale, CA), except for the M07E film (Fig 5) , which was quantified using scanning densitometry.
Leukemic cell line, growth factor deprivation, and add-back. Human megakaryocytic leukemic cells (line M07E). routinely cultured in the presence of 100 U/mL human granulocyte-macrophage (GM)-CSF, were deprived of GM-CSF for 18 hours, followed by the addition of 100 U/mL of human GM-CSF, human L 3 at 8 U/mL, or no add-back of growth factor (deprived). A control culture was maintained continuously in GM-CSF. Cells were harvested 6 hours later, and total cellular RNA was isolated.m RNA was then electrophoresed, blotted, and probed with the indicated cDNA probes.
Synchronized FDC-PI cells, plus or minus growth facror. FDC-P1 cells (growth factor-dependent mouse myeloid leukemic cells provided by Dr J.N. Ihle") were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS) and 25% WEHI-conditioned medium, which supplies the IL-3 that the cells require for proliferation. For synchronization, cells were pelleted, resuspended three times, and then cultured for 36 hours in DMEM without isoleucine, still containing 10% FCS and 25% WEHI-conditioned medium. After isoleucine deprivation for 36 hours, cells were pelleted twice, resuspended in isoleucine-containing DMEM with 10% FCS, either plus or minus 25% WEHIconditioned medium, and then cultured until harvest. These conditions have been demonstrated previously by tritiated thymidine incorporation and thymidine kinase activity time courses to give good cell synchrony in the G , phase of the cell ~y c l e .~~.~~ Control cells were from the same initial flasks of cells, but cultured continuously in isoleucine-containing medium supplemented with FCS and WEHI-conditioned medium, ie, were not synchronized or deprived of growth factor. Cells were harvested at time points by pelleting the cells, washing once in phosphate-buffered saline (PBS), resuspending in 4 mol& guanidinium thiocyanate solution, and vortexing to lyse the cells. Lysates were stored at -20°C until further purification of total RNA by the acid-phenol-guanidinium method:' followed by electrophoresis and blotting as described above. and HM20) but not with IL-3 alone (HMI7 and HM18). Expression of ski was detected in both T and B mature hematopoietic lineage cells (Fig 1, HMI 1 of sno was detected in one mature megakaryocyte sample (HMIO) but not in another mature megakaryoctye sample in which the megakaryocyte identity was better established (HM9). The converse was true for El2 and SCL, which are more abundantly expressed in HM9 than HM10.24a Expression of sno was not seen in normoblastheticulocyte cultures (Fig 1, HM3 and HM4) or neutrophils (Fig I , HM5 and HM6). Expression of sno, like ski, was not detected in proerythroblast/CFU-E cells (HM1 and HM2).
RESULTS
Relative intensities of hybridization by different probes do not provide quantitative information because the specific activities of the different probes were not the same. However, differences in intensity with the same probe on different poly(A) PCR samples probably reflect approximate differences in mRNA quantity. All 80 samples were on a single blot; this same blot was probed with ski and reprobed with sno, as shown in Fig 1 through 4 . This blot was reprobed with 32P-labeled oligo(dT), confirming that the lanes were equally loaded with PCR material (data not shown). The PCR products were run about 1.5 cm into the gel, and hybridizing bands of approximately equal intensity extended this distance down the blot at each position (data not shown). Because of the methodology used, differences in mobility between hybridizing bands are not informative.
To extend this analysis of hematopoietic lineages, we examined cells purified from day 12.5 postcoitum fetal liver. Expression of ski was detected in all fetal liver derivatives (Fig 2) , whereas sno was readily detectable only in one fetal liver sample, FL17, consisting of macrophages from GM precursors in M-CSF (Fig 2, lane FL17) . Also, sno was weakly positive in additional macrophage cultures in which ski expression was highest in this series (Fig 4, FL4 and   FL5 ). Thus, in the fetal liver series, sno expression was detectable only in a small subset of ski-hybridizing populations derived from macrophage precursors in which ski expression was high. This observation was not due to probe crosshybridization; the 3' untranslated region ski RT-PCR and sno cDNA probes do not crosshybridize.
ski and sno Are Dlferentially Expressed in Hematopoietic Precursor Colony-Starts
Blots of poly(A) PCR-amplified samples from bone marrow-derived hematopoietic progenitors show that ski is expressed in the dual-lineage erythrocytdmegakaryocyte progenitors (Fig 3, PR6-12 ; four of seven), but not in tripotential precursors (Fig 3, PRI-5 ; zero of five). Expression of ski was detected at much lower apparent levels in other duallineage precursors: in one macrophagdneutrophil (Fig 3,  PR14 , but not PR13 or PR15 through PR18) precursor and one neutrophiVmast (Fig 3, PR19 but not PR20) dual-lineage precursor. Twenty single-lineage precursor cells were tested, including erythrocyte (Fig 4, two PR40). Expression of ski was not detected in any of the single-lineage precursors at levels comparable with that seen in dual-lineage precursors (Fig 4) . except perhaps the PR25 macrophage precursor.
Like ski, sno is detected in dual-lineage erythrocyte-plusmegakaryocyte precursors (a different set of four of seven; Fig 3) . Unlike ski, sno is detected in additional dual-lineage precursors: macrophage-plus-neutrophil (Fig 3, PR 13 through PR18, six of six) and mast-plus-neutrophil (Fig 3,  PR19 and PR20, two of two). Unlike ski, sno is detected in earlier multilineage precursors (Fig 3, PR1 through PR5 ; trilineage, five of five). Furthermore, sno, but not ski, is readily detected in single-lineage precursors (Fig 4: erythryocyte, two of two; macrophage only, three of eight; neutrophil only, two of six; and megakaryocyte only, four of four). Overall, sno expression is much more widespread in this collection of bone marrow colony-starts than is ski, which is limited to dual-lineage megakaryocyte-erythrocyte precursors. This contrasts with the pattern seen in maturing populations of cells, where ski expression is more widespread than sno (Figs I and 2) .
In progenitor classes expressing ski or sno, there were examples of cells negative for probe hybridization (Fig 3 and  4) . The erythrocytehegakaryocyte dual-lineage progenitors exhibited such heterogeneity, with four of seven positive for ski and sno. However, except for one correspondence (PR1 l), they were a different four positives of the seven precursors. The macrophage single-lineage precursors PR23 2149 ski sno through PR30 also showed heterogeneity, with three of the eight positive for sno expression. All eight were negative for ski expression, except perhaps for weak ski expression in PR25, which showed the strongest sno hybridization of the set.
The sample set of progenitor precursors had nine examples of siblings pairs where two individual cells from a colonystart were separately micromanipulated and subjected to poly(A) PCR. These pairs are bracketed in Figs 3 and 4 . Expression of ski and sno in these sibling pairs was concordant in seven of nine of these pairs. In one discordant example, ski and sno were both expressed in one cell but not in the other of these siblings (PR25 was positive, and PR24 was negative). In the other example, only sno was discordant; sno was expressed in PR7 but not in sibling cell PR8, whereas ski expression was not detected in either cell. As single cells are examined in these experiments, it is possible that examples of discordance may be due to differential expression in two sibling cells at different stages in the cell cycle.
ski, like Id-], Is Expressed and Growth Factor-Modulated in Myeloid Cells
We examined the growth factor responsiveness and expression of ski in factor-dependent myeloid cells that require either IL-3 or GM-CSF for proliferation. Id-], E2A, and ski are expressed in the human M07E megakaryocytic leukemic cell line that is cultured continuously in the presence of GM-CSF (Fig 5) . After deprivation of growth factor, ski and Id-
1 levels drop significantly; 6 hours after add-back of growth factor, ski and Id-l mRNA levels increase dramatically. Thus, both ski and Id-l are growth factor-responsive in these cells. Id-l is a negative regulatory helix-loop-helix (HLH) transcription factor lacking the basic region that binds DNA, with activity in both skeletal muscle and hematopoietic development mediated by complexing with other basic HLH (bHLH) factors." Id-l is known to be induced by growth factor addition to quiescent fibroblast cells, as are Id-2 and Id-3.'' We measured a 30-fold induction of the bHLH transcription factor Id-l in these megakaryocytic cells, comparing the hybridization signal in the IL-3 add-back to the deprived lane (Fig 5) . We also measured a 55-fold reduction in Id-l after growth factor deprivation of the cells. An earlier study found ski mRNA levels induced up to 5.7-fold after phorbol ester (phorbol 12-myristate 13-acetate; PMA) stimulation, which induces megakaryocytic lineage cells to undergo megakaryocytic differentiation.'" Our results measured a 24-fold decrease in ski with growth factor deprivation and a 14.8-fold induction of ski 6 hours after IL-3 addition to deprived megakaryocytic leukemic human M07E cells.
As shown in Fig 5, bHLH factor E2A gene products were less responsive to growth factor deprivation. E2A encodes two alternatively spliced bHLH transcription factors, El2 and E47, that function in both skeletal muscle and hematopoietic lineage^^"^'; this gene was found at the t( 1 ;l 9) translocation in childhood leukemia.28~" E12E47 levels decreased IO-fold in the growth factor-deprived cells relative to the continuously growing culture in the presence of growth factor and then increased threefold in response to IL-3 in the same experiment (Fig 5) . The apparent difference in the response of Id-l and ski levels to IL-3 versus GM-CSF add-back is partly due to differences in RNA loading. The blots shown are duplicates; ethidium bromide-staining intensities and reprobing the blots with a 28s rRNA-derived oligonucleotide probe showed that the GM-CSF lanes \;ere about twofold underloaded with total RNA, but that the others were equally loaded ( Fig  5) . After accounting for loading differences, we still note a difference between IL-3 response of ski and Id-l accumulation levels versus GM-CSF, but not a lack of increase in response to GM-CSF addition. To evaluate whether the difference in response measured at 6 hours might be due to different timing of induction by the two growth factors, we examined RNA isolated over a 24-hour time course after add-back of IL-3 or GM-CSF. We found that ski and Id-1 expression levels increased more slowly after GM-CSF addback than after IL-3 (data not shown). Levels of ski and Id-l were maximal at 2 to 6 hours after IL-3 add-back, but were maximal only after 24 hours had elapsed since GM-CSF addback (for ID-l, see Quesenbeny and Pearson-White, manuscript in preparation; for ski, S.P.-W. unpublished data).
ski and sno Are Expressed and Modulated in Synchronized Myeloid Cells in Response to Changes in Growth Factor and Cell Cycle
The modulation in ski mRNA levels in response to growth factor deprivation and add-back (Fig 5 ) suggested that ski might be cell cycle-regulated in hematopoietic cells. We therefore examined ski expression in synchronized myeloid lineage cells, both in the presence and absence of growth factor. Cell synchrony was achieved using isoleucine deprivation and add-back,"." which synchronizes the cells in early to mid-G, .?' Both synchronized and unsynchronized cells expressed ski at the zero time point of the experiment (Fig 6A and B) . Cells released from the isoleucine block in the presence of growth factor showed significant increases in the levels of both hybridizing bands of ski as the cells progressed through cycle. Levels of ski peaked in mid-tolate G,, 2 to 8 hours after isoleucine addition. The two different size InRNA species seen for both murine ski ancl sno are believed to differ at their 3' (or 5') untranslated ends and not in the protein-coding region (Nomura et a14 and Lyons et al""). These are not seen in human ski and sno (Fig  5) . Levels of ski mRNA decreased after the mid-G, peak as the cells continued through the cycle into S phase, which takes place between 12 and I6 hours after isoleucine addition in these cells.23 This timing was confirmed by reprobing the blots with the mouse histone H2a probe, which is upregulated as cells move from G , into S phase.'" H2a showed a significant increase in hybridization I2 hours after isoleucine block release (Fig 6A and B) .
These data show that ski mRNA expression is cell cycle-modulated, peaking in the mid-to-late G , phase of the cell cycle. Figure 6B shows the quantitated average from all three separate Northern blots made from cells in this experiment. An independently performed duplicate experiment gave similar results (not shown). To normalize for differences in hybridization probe specific activity, the hybridization intensities from the phosphorimager were divided by the total hybridization for each blot and presented as the mRNA level (Fig 6B) . The error bars show the standard deviations calculated from the three averaged data sets. Each blot was re-2151 ski sno probed with GAPDH to confirm that the lanes were equally loaded with total RNA: as before, a representative example is presented in Fig 6A, and all three examples are averaged in the graph (Fig 6B) . GAPDH levels appeared to decrease during the time course in synchronized cells in the absence of growth factor. Two other probes showed equal hybridization signals on this series of samples (E12 and SCL; data not shown), suggesting that the loading was equal and that GAPDH was decreasing under these conditions. 111 the absence o f growth factor, syrlcllrorlizcd cells suppressed expression of ski as the cells were released from isoleucine block. Levels of ski decreased most dramatically between 2 and 8 hours after isoleucine add-back in the absence of growth factor (Fig 6A) .
Levels of sno varied with the cell cycle as well, but with more fluctuation in the signal intensities. The 7.6-kb species of sno increased significantly after the initial isoleucine addback (zero time point) and then decreased by 8 hours.
Whereas ski mRNA accumulation showed only a single maximum of expression during the time course, which includes only a single cell cycle, 7.6 kb sno levels increased a second time at 12 hours, as the cells enter the S phase of the cycle. Increases and decreases in 7.6-kb sno levels in the absence or presence of growth factor were comparable during the course of the cell cycle. The 3.6-kb sno mRNA species showed little variation in these experiments (Fig 6A: omitted  from Fig 6B) . The two isoforms seen for sno have not been completely sequenced and characterized in the mouse, but are believed to differ in the length of the 3' untranslated regions, like ski. and not in the protein-coding regions (Nomura et a14) . relatively high levels of both ski and sno at the zero time point of the experiment. When we repeated this experiment, we tested whether the mRNAs showed increased expression between the start of the manipulations and our zero time point, which is the time the cells are returned to the incubator (or harvested for the zero time point) and about 30 to 40 minutes after beginning to wash the cells back into the isoleucine-containing medium. We found that ski and sno levels are very low before beginning the isoleucine add-back (data not shown). The expression levels begin to respond to isoleucine add-back when it is first added, which is a 30-to 40-minute washing interval before our zero time point begins. Thus, the ski and sno levels at the zero time point are already increased over the unmanipulated, isoleucine-deprived cells. These data do not rule out the possibility that the expression levels are also responsive to other stimuli from these manipulations. As the probe levels showed significant increases and decreases as the cells proceeded through G, after release from the isoleucine deprivation block in early G I , but not in unsynchronized cells, the washing perturbation is not the sole cause of the changes noted (Fig 6) . Furthermore, histone H2a and H3.2 levels were not increased during this initial washing period (data not shown). This is consistent with the idea that the cells are re-entering the cycle at the beginning of the isoleucine addition, before the zero time point shown, and ski and sno levels respond early, whereas other mFWA expression is activated at later points in the cycle. Whereas other probes showed a single peak of expression during a single cell cycle, sno levels peak twice within the same cell cycle. (Additional data included in Fig 6B, especially in the absence of growth factor, are more convincing on this point than the data in the autoradiogram shown in Fig 6A) . This and the histone H2a pattern suggest that ski and sno are not merely responding to the stimulation from the cell washing and manipulations, but undergo increases and decreases over the course of cell cycle progression.
Both synchronized and unsynchronized cells expressed
Synchronized FDC-P1 cells deprived of growth factor are unable to proliferate and may undergo apoptosis. The viable cell counts in this population decrease over the time course of the experiment. Reprobing the blots with histone probes H2a (Fig 6) and H3.2 (not shown) showed that there was some increase in expression of these mRNAs at 12 hours in the absence of growth factor. This suggests that a portion of the cells in the absence of growth factor are at least partially continuing through the cycle.
DISCUSSION
In this report, we describe ski and sno mRNA expression in various hematopoietic lineages, including individual normal murine marrow progenitors analyzed by single-cell RT-PCR. We found that ski was expressed in both B-and Tlineage mature lymphopoietic cells from murine fetal liver, as well as in mature macrophages and mast cells in the myeloid lineage. In marrow-derived progenitors, however, ski expression was readily detected only in dual-lineage megakaryocyte/erythrocyte colony-starts. Expression of sno was expressed in mature T lymphopoietic cells, but not in Blineage cells. Expression of sno was more widespread in marrow-derived progenitor colony-starts and was found consistently in tri-, dual-, and single-lineage progenitors. Expression of ski, like Id-l, was induced by IL-3 addition to growth factor-deprived human megakaryocytic M07E cells. We found also that ski and sno were cell cycle-regulated in synchronized factor-dependent mouse myeloid cells. Expression of ski peaked in mid-GI in cells synchronized by isoleucine deprivation in the presence of growth factor, but decreased rapidly in the absence of growth factor. Expression of sno increased substantially in response to isoleucine addback in early to mid-G,, then decreased, increased, and decreased again as the cells continued through cycle. The same The finding of ski expression in megakaryocyte/erythrocyte dual-lineage progenitors was consistent with the recent report that ski responds to growth factor or phorbol ester stimulation of cells in the megakaryocyte lineage." Cell lines in other lineages, notably those that differentiate along the erythroid, monocyte, or granulocyte pathways (HL60 cells), were found not to increase ski mRNA levels in response to factors used to induce differentiation." It was notable that ski expression was not detected in any other progenitors, including tri-lineage and single-lineage progenitors.
No probes tested other than ski, including those in the bHLH transcription factor class (Quesenberry and Pearson-White, manuscript in preparation), were limited to a single type of progenitor. We found that ski was expressed in mature, larger, fetal liver-derived populations of B-and T-cell lymphopoietic lineage cells, as well as in mature mass populations of mast cells in the myeloid lineage. It was also expressed in fetal liver-derived macrophages and, to a lesser extent, in B cells derived from macrophagern cell dual-lineage cells. Expression of ski was also noted in macrophages from other fetal liver-derived populations, but not in bone marrow-derived colony-start macrophages.
In M07E cells, a human megakaryocytic leukemic cell line dependent on either IL-3 or GM-CSF for proliferation, we found that ski and Id-l levels were growth factor-responsive, decreasing in the absence of growth factor and returning within 6 hours after IL-3 add-back. Expression of sno mRNA (data not shown) was low and much less responsive to growth factor deprivation and add-back in these cells than was ski.
We examined cell cycle regulation of ski in synchronized mouse myeloid cells that are not megakaryocytic and do not differentiate along the megakaryocyte lineage (FDC-PI). In these cells, ski mRNA is increased in the mid-G, phase of the cell cycle in the presence of growth factor, but decreases in the absence of growth factor. Both ski mRNA isofoms showed maximum expression in mid-G, (Fig 6) . The cell cycle expression pattern of ski closely paralleled that of Id-1, which showed maximal expression 2 hours after isoleucine addition (Quesenbeny and Pearson-White, manuscript in preparation). This was reminiscent of the close similarity between ski and Id-l induction after IL-3 deprivation and add-back to megakaryocytic M07E cells (Fig 5) .
Although ski and Id-1 induction patterns were very similar in response to growth factors and during the cell cycle, their expression patterns differed significantly in hematopoietic progenitor colony-starts and mature populations. Id-l expression was detected in multiple examples of both duallineage and single-lineage progenitors, whereas ski was limited to erythrocyte/megakaryocyte dual-lineage progenitors. Expression of both ski and Id-l was detected only in PR6 and PR1 2 cells. Expression of ski was widespread in the mature hematopoietic populations (Fig l) , but Id-l expression was limited to just the HMI1 and HM12 B220+, B cell fetal liver-derived cells. Expression of ski was also widespread in fetal liver-derived cells, but Id-l was more limited to the sorted cell populations and not found in the macrophage/B-cell colony-derived cells (FLl-10; for Id-I data, see Quesenberry and Pearson-White, manuscript in preparation). Expression of sno in hematopoietic progenitor colonystarts and mature populations differed from both ski and Id-I . Expression of sno was limited to T cells, Id-1 was limited to B cells, and ski was expressed in both B and T cells. Expression of sno was found in at least two myeloid progenitor colony-starts in each class. Neither ski, Id-l, E12E47, X L , nor lyl-l showed as widespread expression as sno in the progenitor colony-starts tested (bHLH data in Quesenberry and Pearson-White, manuscript in preparation).
Expression of sno was found in trilineage early progenitors that gave rise to erythrocytes, megakaryocytes, and macrophages, whereas ski and Id-l were not expressed in these early progenitors.
The regulation of sno expression differed from ski and Idl . Expression of sno mRNA was cell cycle-regulated, with a maximum expression peak at the zero time point in earlyto-mid G , , which is 30 to 40 minutes after isoleucine addition, followed by a decline and then a second peak. In a repetition of the cell synchrony experiment (not shown), the sno maximum was again at zero and minima were at 2, 12, and 24 hours, with additional peaks at 8, 16, and 48 hours. Thus, although sno levels consistently show a maximum at the zero time point, in mid-to-early G , , the sno mRNA level oscillates thereafter, and the absolute timing is not consistent for these oscillations.
The profile of sno expression in unsynchronized cells, with a peak at the zero time point and declines thereafter at 8 and 24 hours, raises the possibility that sno expression was stimulated by cell manipulations (spinning, washing into fresh media) and then declined unevenly. However, Id-l and H2a also showed declining expression in unsynchronized cells at 8 and 24 hours. We tested whether our manipulations stimulated expression of these genes by examining mRNA expression before and after the isoleucine add-back and found that there was significant stimulation of ski and sno (and Id-l, but not H2a or H3.2) expression in synchronized cells after the 30-to 40-minute washing period, as compared with before these manipulations (data not shown). However, the stimulated genes are those expressed in G , , with those not expressed until later remaining unstimulated. Thus. the results are consistent with a cell cycle-regulated pattern, with G,-expressed genes stimulated immediately after isoleucine add-back. Also, because sno expression has a second increase (at 12 hours) after a decline (at 8 hours), during which time the cells are not remanipulated, it is unlikely that the induction of sno activity is a simple artifactual stimulation. As ski expression was steady throughout the time course in unsynchronized cells, and the ski increase was subsequent to the zero time point, the ski pattern cannot be due to artifactual stimulation of the cells by the experimental manipulations.
There was no apparent difference in the pattern of sno expression between isoleucine add-back in the presence or absence of growth factor (Fig 6) . When we reprobed the M07E blots to examine whether sno levels changed in response to growth factor deprivation or addition, we also measured little apparent growth factor response (data not
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From shown). In contrast, in quiescent 10T1/2 fibroblasts, we find that sno is induced with immediate early kinetics by serum addition (manuscript in preparation). As with ski,'3 we will likely find that sno responds only in a subset of cell types, and only to certain growth factors.
